Point72 Asset Management
PYXS icon

Point72 Asset Management’s Pyxis Oncology PYXS Stock Holding History

Point72 Asset Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46.7K Sell
32,006
-156,130
-83% -$235K ﹤0.01% 3664
2025
Q4 		$216K Buy
+188,136
New +$664K ﹤0.01% 3610
2023
Q2 		– Sell
-251,800
Closed -$1.01M – 2670
2023
Q1 		$1.01M Buy
+251,800
New +$503K ﹤0.01% 1105

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management's PYXS Position: Q1 2026 in Review

Point72 Asset Management reduced its Pyxis Oncology (PYXS) stake by 83% in Q1 2026, selling an estimated $235K and leaving 32,006 shares worth $46.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3664.

Point72 Asset Management first reported a position in PYXS in Q1 2023 and has held it in 3 quarters since. The position peaked at $1.01M in Q1 2023. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • Point72 Asset Management held 32,006 shares of Pyxis Oncology worth $46.7K as of Q1 2026.
  • Point72 Asset Management sold 156,130 Pyxis Oncology shares in Q1 2026, an estimated $235K.
  • Pyxis Oncology made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3664 holding.
  • Point72 Asset Management first reported a position in Pyxis Oncology in Q1 2023 and has held it in 3 quarters since.
  • Point72 Asset Management's Pyxis Oncology position peaked at $1.01M in Q1 2023.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.